Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A XNAS: KNSA

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A
Rating: 1.826305625
Author: Trendlyne DVM scores

Expensive Performer

Download real time

23.81 0.73 (3.16%)

43.78% Gain from 52W Low

592.3K XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Medium Financial Strength

38.9 / 100

Expensive Valuation

16.2 / 100

Technically Neutral

52.2 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

36

1Yr Price target upside is 51%

7 analysts

Kiniksa Pharmaceuticals Lt... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A FAQ

How is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A today?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A today is trading in the green, and is up by 3.16% at 23.81.

How has Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A performed historically?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A is currently trading up 3.16% on an intraday basis. In the past week the stock rose 5.82%. stock has been up 16.20% in the past quarter and rose 20.86% in the past year. You can view this in the overview section.